V2-U scDb

N/A

Report date: 2026/03/19 16:59:50

Base Information

Drug NameV2-U scDb

Drug Alias NameV-2-U scDbV2-U scDb

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionGTPase Ras inhibitorsAnti-CD3

TargetsT cell surface glycoprotein CD3GTPase Ras

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A